(NASDAQ: MDXH) Mdxhealth Sa's forecast annual revenue growth rate of 12.07% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.95%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.03%.
Mdxhealth Sa's revenue in 2024 is $70,193,000.On average, 2 Wall Street analysts forecast MDXH's revenue for 2024 to be $2,158,856,615, with the lowest MDXH revenue forecast at $2,157,369,520, and the highest MDXH revenue forecast at $2,160,343,711. On average, 2 Wall Street analysts forecast MDXH's revenue for 2025 to be $2,405,579,223, with the lowest MDXH revenue forecast at $2,369,618,558, and the highest MDXH revenue forecast at $2,441,539,888.
In 2026, MDXH is forecast to generate $2,575,378,454 in revenue, with the lowest revenue forecast at $2,575,378,454 and the highest revenue forecast at $2,575,378,454.